LGC Capital to Expand Global Footprint in Medical Cannabis Market Through Investment in Jamaica's Global Canna Labs Limited

LGC Capital Ltd.Symbol: TSX-V: LG

• LGC to subscribe for a $2.5 million secured debenture of Jamaican cannabis company Global Canna Labs Limited, convertible into an initial 30% interest, and to acquire a 5% royalty on net sales.
• The Jamaican Cannabis Licensing Authority granted Global Canna Labs conditional approval for a Cultivator's Licence (Tier 3) (over 5 acres) on December 20, 2017 .
• Global Canna Labs plans to start cultivation of its first commercial cannabis crop by Q2 2018.
• Construction of Global Canna Labs' first dispensary is expected to start in Q1 2018 in Montego Bay's Hip Strip.
• Plans are also in place for Global Canna Labs to open an on-site farm store and a dispensary in Kingston, Jamaica by the end of 2018.

MONTREAL , Jan. 26, 2018 /CNW Telbec/ - LGC Capital Ltd. (LG.V) ("LGC") is pleased to announce that it has signed a Letter of Intent with rapidly-developing Jamaican cannabis company Global Canna Labs Limited ("Global Canna Labs") for a strategic investment in the Jamaican cannabis market as part of LGC's ongoing international expansion.

View photos

View original content with multimedia: http://www.newswire.ca/en/releases/archive/January2018/26/c1672.html